Brian Kannard

Brian Kannard is the Chief Executive Officer of PercuSense, a startup company based in the Los Angeles Metropolitan Area.1 He has been in this role since October 2017, leading the company's efforts in developing innovative healthcare technology.1

Professional Background

Kannard has an extensive background in medical device development and leadership:

Medtronic Experience::

• Prior to joining PercuSense, he worked at Medtronic for several years in various roles.1
• His most recent position at Medtronic was Engineering Director of CGM Product Development from December 2015 to October 2017.1
• He led teams responsible for developing and commercializing the Guardian Sensor 3, the world's first FDA-approved CGM system for hybrid closed-loop insulin delivery.1

Other Leadership Roles::

• Concurrent with his role at PercuSense, Kannard is also the CEO of Flotherm, a position he has held since October 2017.1

Education

Kannard has a strong educational background:

• He holds an MBA from Stanford University Graduate School of Business, where he was an Arjay Miller Scholar (top 10% of his graduating class).1
• He completed his Bachelor of Science in Biomedical Engineering with a minor in Economics from the University of Southern California, graduating Summa Cum Laude with a 3.92 GPA.1

Current Role at PercuSense

As CEO of PercuSense, Kannard is leading a company focused on:

• Developing a continuous multi-analyte sensor system that combines monitoring of multiple biosensors with knowledge of disease progression.1
• Creating technology to help healthcare professionals and patients make better healthcare decisions.1
• Pursuing research and development in areas such as diabetes, continuous hospital monitoring, and applications for military and first responders.1

Kannard's experience in medical device development, particularly in continuous glucose monitoring systems, aligns closely with PercuSense's mission to advance healthcare technology and improve patient outcomes.